IFNA1 and chronic kidney disease: Nevertheless, in KTRs, median IFN-ɣ levels at 6 months were not significantly lower vs at 28 days, opposed to an observed significant decline in controls, CKD G4/5 patients, and dialysis patients (Figure 5B).